PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

被引:428
作者
Song, S
Ewald, AJ
Stallcup, W
Werb, Z
Bergers, G
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[5] Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA
关键词
D O I
10.1038/ncb1288
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The microvasculature consists of endothelial cells and their surrounding pericytes. Few studies on the regulatory mechanisms of tumour angiogenesis have focused on pericytes. Here we report the identification of tumour- derived PDGFR beta(+) ( platelet- derived growth factor receptor beta) progenitor perivascular cells ( PPCs) that have the ability to differentiate into pericytes and regulate vessel stability and vascular survival in tumours. A subset of PDGFR beta(+) PPCs is recruited from bone marrow to perivascular sites in tumours. Specific inhibition of PDGFR beta signalling eliminates PDGFR beta(+) PPCs and mature pericytes around tumour vessels, leading to vascular hyperdilation and endothelial cell apoptosis in pancreatic islet tumours of transgenic Rip1Tag2 mice.
引用
收藏
页码:870 / U16
页数:12
相关论文
共 43 条
[1]   Analysis of mural cell recruitment to tumor vessels [J].
Abramsson, A ;
Berlin, Ö ;
Papayan, H ;
Paulin, D ;
Shani, M ;
Betsholtz, C .
CIRCULATION, 2002, 105 (01) :112-117
[2]   HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[3]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[4]  
Benjamin LE, 1998, DEVELOPMENT, V125, P1591
[5]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[6]  
Bergers G, 1998, INT J DEV BIOL, V42, P995
[7]   Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].
Bergers, G ;
Song, S ;
Meyer-Morse, N ;
Bergsland, E ;
Hanahan, D .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295
[8]  
Betsholtz C, 2005, EXP SUPPL, V94, P115
[9]   Insight into the physiological functions of PDGF through genetic studies in mice [J].
Betsholtz, C .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :215-228
[10]   Developmental roles of platelet-derived growth factors [J].
Betsholtz, C ;
Karlsson, L ;
Lindahl, P .
BIOESSAYS, 2001, 23 (06) :494-507